UVUfuk Vardar

Ufuk Vardar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ufuk Vardar has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety and Outcomes of Transvenous Lead Extraction of Advisory ePTFE-Coated Implantable Cardioverter-Defibrillator Leads

    by Mohamed Gad, Balaram Krishna Hanumanthu, Yong-Mei Cha, Zhiyong Qian, Fred M. Kusumoto, Danesh Kella, Ufuk Vardar, Rohit Mehta, Satish K. Misra, Neel Patel, et al.

  • Open Access

    Multimodality Risk Stratification in Athletes With Long QT Syndrome

    by Kevin G. Tayon, Ufuk Vardar, Elizabeth H. Dineen, Brian P. Shapiro, Fred Kusumoto, Andrew S. Tseng

  • Subclinical Venous Injury in Transvenous Lead Extraction: Histological Correlation With Clinical Risk Factors

    by Azalfa U. Lateef, Ufuk Vardar, Alex Hochwald, Aziza Nassar, Thomas Ladas, Anca Chiriac, Christoffel Van Niekerk, Fred Kusumoto, Danesh K. Kella

    Background: Transvenous lead extraction (TLE) is a commonly performed and generally safe procedure, though procedural complexity and risk can vary based on clinical and procedural factors. Objective: This study aims to identify clinical and procedural factors associated with histologic evidence of subclinical vascular injury, defined by elastin positivity on extracted leads and its clinical significance. Methods: Patients undergoing TLE with a lead dwell time of ≥ 1 year were included. Extracted leads with tissue were analyzed histologically using Verhoeff–Van Gieson staining to assess the presence of elastin. Demographic data, procedural and lead characteristics, and indication for extraction were obtained. Established extraction risk scores were calculated to determine efficacy in predicting subclinical vascular injury. Results: The cohort included 49 patients with 92 leads extracted. A total of 25 patients (51%) had elastin‐positive leads. Complete procedural success occurred in 95.9% of cases. The multivariate regression model did not identify any independent predictors of elastin presence, including age (OR = 1.00; 95% CI 0.95–1.05; p = 0.89), female gender (OR = 3.04; 95% CI 0.67–13.65; p = 0.14), lead dwell time (OR = 1.13; 95% CI 0.98–1.29; p = 0.07). Additionally, no scoring system, such as the CCF, EROS, MB, SAFeTY, and LECOM, predicted the presence of elastin. Conclusion: Subclinical venous injury was common following TLE, yet did not predict adverse clinical outcomes, reinforcing that TLE performed in experienced centers carries a favorable safety profile. Future studies in larger cohorts are needed to further characterize the clinical utility of subclinical vascular injury.

  • Open Access

    Repetitive Non–Re-Entrant Ventriculoatrial Synchrony Causing Heart Failure Exacerbation

    by Ufuk Vardar, James F. Howick, Carlos Vergara Sanchez, Jeanwoo Yoo, William Mai, Bridget Lee, Iain Thompson, K.L. Venkatachalam

  • Management of Lead-Related Superior Vena Cava Syndrome

    by Ufuk Vardar, Isaac Burright, Bridget Lee, Fred Kusumoto, Yong-Mei Cha, Abhishek J. Deshmukh, Siva K. Mulpuru, Christoff Van Niekerk, Anca Chiriac, Andrew Lewis, et al.


  • Open Access

    Predictors and Trends of 30-day Readmissions in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insight From the National Readmission Database

    by Sean DeAngelo, Rohan Gajjar, Gianfranco Bittar-Carlini, Badri Aryal, Bhannu Pinnam, Sharan Malkani, Ufuk Vardar, Yasmeen Golzar

    DeAngelo S, et al. Int J Heart Fail. 2025 Jan;7(1):21-29. https://doi.org/10.36628/ijhf.2024.0041


  • A Case of Biventricular Stress-Induced Cardiomyopathy

    by Ufuk Vardar, Jenna Bilodeau-Gandre, Awais Malik

    **Introduction/Hypothesis:** Here, we present a 47-year-old woman presenting to our emergency department with fatigue, bilateral lower extremity | POSTER

  • Open Access

    Gender disparities, causes and predictors of immediate and short-term cardiovascular readmissions following COVID-19-related hospitalisations in the USA

    by Ufuk Vardar, Hafeez Shaka, Dennis Kumi, Rohan Gajjar, Olva Bess, Philip Kanemo, Abdultawab Shaka, Naveen Baskaran

    Objectives In this study, we aimed to identify the causes, predictors and gender disparities of 30-day and 90-day cardiovascular readmissions after COVID-19-related hospitalisations using National Readmission Database (NRD) 2020. Setting We used the NRD from 2020 to identify hospitalised adults with a principal diagnosis of COVID-19 infection. Participants We included subjects who were readmitted within 30 days and 90 days after index admission. We excluded subjects with elective and traumatic admissions. We used a multivariate Cox regression model to identify independent predictors of readmission. Primary and secondary outcomes measures Our outcomes were inpatient mortality, 30-day and 90-day cardiovascular readmission rates following COVID-19 infection. Results During the study period, there were 1 024 492 index hospitalisations with a primary diagnosis of COVID-19 infection in the 2020 NRD database, 644 903 (62.9%) were included for 30-day readmission analysis, and 418 122 (40.8%) were included for 90-day readmission analysis. Of patients involved in the 30-day analysis, 7140 (1.1%) patients had a readmission within 30 days; of patients involved in the 90-day analysis, 8379 (2.0%) had a readmission within 90 days due to primarily cardiovascular causes. Cox regression analysis revealed that the female sex (aHR 0.89; 95% CI 0.82 to 0.95; p=0.001) was associated with a lower hazard of 30-day cardiovascular readmissions; however, congestive heart failure (aHR 2.45; 95% CI 2.2 to 2.72; pConclusion Our study demonstrates that male gender, heart failure, arrhythmias and valvular disease carry higher hazards of 30-day and 90-day cardiovascular readmissions. Identifying risk factors and common causes of readmission may assist with lowering the burden of cardiovascular disease in patients with COVID-19 infection.


  • Open Access

    Social and clinical predictors of 90-day readmission after hospitalization for pacemaker implantation in patients with dementia: insight from the National Readmissions Database

    by M Kodali, R Atluri, M Vallabaneni, S Yalamanchili, S Shoura, U Vardar

    Background: Patients with dementia are one of the most common subpopulations that are at risk for readmission and are responsible for a significant burden on American healthcare resources. In addition to this, many studies have shown poor outcomes with dementia patients undergoing invasive procedures. Nonetheless, dementia patients presenting with conditions such as high degree heart block and sinus node dysfunction still require pacemaker implantation (PMI). Purpose: We aimed to analyze social and clinical predictors of readmission in those with Dementia who were admitted for PMI. Methods: We utilized the National Readmission Database (NRD) from 2018 to identify adults hospitalized for pacemaker implantation (PMI) who also had dementia. We included those who were readmitted within 90 days after the index admission. We excluded elective and traumatic admissions. A multivariate cox regression model was used to identify independent predictors of readmission. Results: In our study, 7,529 patients with dementia who were hospitalized for pacemaker implantation (PMI) were discharged alive. Within 90-days from discharge, 1,250 (16.6%) were readmitted. The top three causes of readmission were heart failure (12.2%), sepsis (8%), and acute kidney injury (5%). Readmitted patients had more comorbidities (≥3; 64.4% vs 57.3%; p<0.001), higher rates of intubation (4.9% vs 1.59%; p<0.001) and annual income < $44,000 (29.39% vs 25.7%; p=0.03). In-hospital mortality (3.9% vs 1.27%; p<0.001) was higher during readmission. Figure 1 shows the Forrest plot of multivariate analysis of independent factors associated with readmissions. Conclusion: We identified predictors of readmission after hospitalization for PMI in dementia patients such as household income, leaving against medical advice, federal insurance, heart failure, atrial flutter, and liver disease during their index admission. Healthcare systems should use this data to have an open discussion with caregivers and family members to weigh the prognosis on a case by case basis prior to pacemaker implantation in this population.

  • Open Access

    Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

    by M Kodali, R Atluri, S Yalamanchili, S Shoura, U Vardar

    Background: Atrial Fibrillation (AF) poses a significant burden on the American Healthcare system. Heart failure and AF commonly coexist in patients. Elevated left ventricular and atrial pressures result in progressive left atrial dilation and remodeling which in turn predisposes to the generation of AF. Many of these patients develop pulmonary hypertension (PHT) due to the remodeling and elevated left-sided pressures. Cardioversion (CV) for non-valvular atrial fibrillation (AF) is commonplace for patients during their initial presentation. Since many who undergo CV for AF could have PHT, we aimed to assess the periprocedural outcomes in this population. Methods: We utilized the National Inpatient Sample from 2016-2019 to identify roughly 330,820 hospitalized adults who had CV for AF. These hospitalizations were further stratified based on the presence of PHT. A multivariate regression model was used to adjust for confounders and analyze the variables. Results: Of those who underwent CV for AF, 45,345 (13.7%) had PHT. In-hospital mortality was interestingly lower in those with PHT (9.6% vs 10.37%; p<0.001). Figure 1 shows the Forrest plot for multivariate analysis of in-hospital outcomes when adjusted for patient demographics, comorbidities, and hospital characteristics. When adjusted similarly, patients who underwent CV for AF and PHT had longer length of stay (LOS) by 2.11 days (p<0.001) and had additional hospital costs (HC) of $29,470 (p<0.001). Conclusion: In this study, patients who underwent CV for AF with co-existing PHT had significantly worse outcomes in terms of LOS, HC, pulmonary embolism, atrial flutter, VT, SVT, AKI, and intubation. Of note, they interestingly had better outcomes in terms of in-hospital mortality, respiratory failure, and strokes. Returning the patient to sinus rhythm likely improved the left heart hemodynamics reducing post capillary pulmonary hypertension explaining the reduced mortality rate in this population. One major limitation of our study is the lack of outpatient follow up and the inability to differentiate between the different groups of PHT. Since several outcomes are worse in the setting of PHT, potential strategies for aggressive rate and volume control for those in AF should be pursued to avoid negative cardiac remodeling that would predispose to the development of PHT. AF patients with co-existing PHT should be aggressively monitored during hospitalizations as they have the potential to have worse outcomes.